The pharma giant Bristol-Myers Squibb Co.'s $74 billion takeover of Celgene, the largest healthcare deal in history, is in jeopardy after Bristol-Myers' ...
News
- Bristol-Myers' record-breaking $74 billion biotech deal is in jeopardy (BMY, CELG)
- Scientists just made marijuana compounds in a lab for the first time, and it could open the door to ...
... works, including Ginkgo Bioworks, a synthetic-biology startup in Boston; Intrexon, a biotech in Maryland; and Hyasynth Bio, a Canadian startup.
- How Many Bristol-Myers Squibb Company (NYSE:BMY)'s Analysts Are Bullish?
... article titled: “Another San Antonio biotech changing its name and CEO – San Antonio Business Journal” with publication date: February 26, 2019.
- Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR
... Oncolytics Biotech, and his colleagues, in collaboration with Northwestern University, UT Health San Antonio and Adaptive Biotechnologies, can be ...
- China drafts rules on biotech after gene-editing scandal
BEIJING (AP) — China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist's ...